We are live on ! Find out more
MDNA

Medicenna Therapeutics Corp. Common Shares
MDNA

Delisted

MDNA was delisted on the 1st of November, 2023.

Back to rankings

1 hedge funds and large institutions have $175K invested in Medicenna Therapeutics Corp. Common Shares in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $145K → $175K (+$30K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OP
ORG Partners
Indiana
+$35K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
OP
1
ORG Partners
Indiana
$175K +$35K +25,000 +25%

MDNA Hedge Fund Activity: Q3 2024 in Review

1 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Medicenna Therapeutics Corp. Common Shares (MDNA) for Q3 2024, worth a combined $175K — up 21% from $145K a quarter earlier.

Fund positioning in MDNA was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was ORG Partners, adding an estimated $35K.

  • 1 institutional investor held Medicenna Therapeutics Corp. Common Shares (MDNA) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $175K of Medicenna Therapeutics Corp. Common Shares stock for Q3 2024, up 21% quarter-over-quarter.
  • 0 funds opened new Medicenna Therapeutics Corp. Common Shares positions in Q3 2024 and 0 closed out.
  • The largest Medicenna Therapeutics Corp. Common Shares buyer in Q3 2024 was ORG Partners, an estimated $35K added.

Based on aggregated 13F filings for Q3 2024.